Chinese Mecobalamin Market Outlook 2017-2022

Chinese Mecobalamin Market Outlook 2017-2022

Gen Consulting Company | ID: 1524027654186 | Published at: 2017-11-11 | Pages: 92

  • €2.371,88


Methylcobalamin is equivalent physiologically to vitamin B12, and can be used to prevent or treat pathology arising from a lack of vitamin B12 (vitamin B12 deficiency), such as pernicious anemia. The study provides historic data of 2012-2016 along with a forecast from 2017 to 2022 based on both output/volume and revenue. The study then describes the drivers and restraints for the mecobalamin market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the mecobalamin market.

The report has been prepared based on the synthesis, analysis, and interpretation of information about the Chinese mecobalamin market collected from specialized sources. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. Company overview, financial overview, product portfolio, new project launched, recent development analysis are the parameters included in the profile. Relevantly, the report and company profiles specify the key drivers that are impacting the demand in Chinese mecobalamin market.

Key Vendors
• Eisai
• Shandong Keyuan
• Chongqing Lummy
NCPC
• Hebei Yuxing
• Ningxia Kingvit
• request free sample to get a complete list of companies

Key Questions Answered in this Report
• What will the market size be in 2022?
• What are the key factors driving the Chinese mecobalamin market?
• What are the challenges to market growth?
• Who are the key players in the mecobalamin market?
• What are the market opportunities and threats faced by the key players?

Part 1. Exclusive Summary

Part 2. Methodology

  • 2.1 Research Methodology
  • 2.2 Years Considered

Part 3. Introduction

  • 3.1 Product Overview
  • 3.2 Manufacturing Process
    • 3.2.1 Raw Materials
    • 3.2.2 Cost Analysis

Part 4. Competitive Landscape

  • 4.1 Chinese Mecobalamin Market, by Volume 2012-2017
    • 4.1.1 Overview
    • 4.1.2 Chinese Mecobalamin Market, by Volume, by Company
    • 4.1.3 Top 5 Companies by Volume Share
  • 4.2 Chinese Mecobalamin Market, by Revenue 2012-2017
    • 4.2.1 Overview
    • 4.2.2 Chinese Mecobalamin Market, by Revenue, by Company
    • 4.2.3 Top 5 Companies by Revenue Share
    • 4.2.4 Price & Gross Margin

Part 5. Consumption Pattern

  • 5.1 Consumption
  • 5.2 Import & Export

Part 6. Situation & Prospect

  • 6.1 Situation
  • 6.2 Market Prospect

Part 7. Market Dynamics

  • 7.1 Market Drivers
  • 7.2 Challenges
  • 7.3 Market Trends

Part 8. Mecobalamin Market Forecast

  • 8.1 Chinese Mecobalamin Market Size 2017-2022
  • 8.2 Chinese Mecobalamin Consumption 2017-2022

Part 9. Company Profiles

  • 9.1 Eisai
    • 9.1.1 Business Overview
    • 9.1.2 Products Offered
    • 9.1.3 Financials
  • 9.2 Shandong Keyuan
  • 9.3 Chongqing Lummy
  • 9.4 NCPC
  • 9.5 Hebei Yuxing
  • 9.6 Ningxia Kingvit
  • 9.7 Shandong Chenlong
  • 9.8 Haiyou Freda
  • 9.9 Beijing Lunarsun
  • 9.10 Weihai Disu

Part 10. Appendix

  • 10.1 Abbreviations
  • 10.2 Disclaimer

Get in touch!

Looking for sample pages? Or want to speak to someone about discounts?

Please leave your details and we'll get back to you as soon as we can!